These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 26489628)

  • 1. Synaptic vesicle protein2A decreases in amygdaloid-kindling pharmcoresistant epileptic rats.
    Shi J; Zhou F; Wang LK; Wu GF
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):716-722. PubMed ID: 26489628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal low-frequency stimulation increased SV2A expression and inhibited the seizure degree in pharmacoresistant amygdala-kindling epileptic rats.
    Wang L; Shi J; Wu G; Zhou F; Hong Z
    Epilepsy Res; 2014 Nov; 108(9):1483-91. PubMed ID: 25205164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low-frequency hippocampal stimulation on gamma-amino butyric acid type B receptor expression in pharmacoresistant amygdaloid kindling epileptic rats.
    Wu G; Hong Z; Li Y; Zhou F; Shi J
    Neuromodulation; 2013; 16(2):105-13. PubMed ID: 22882360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal low-frequency stimulation improves cognitive function in pharmacoresistant epileptic rats.
    Wang L; Shi H; Kang Y; Guofeng W
    Epilepsy Res; 2020 Dec; 168():106194. PubMed ID: 31521425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA expression of activity-regulated cytoskeleton-associated protein (arc) in the amygdala-kindled rats.
    Akiyama K; Ishikawa M; Saito A
    Brain Res; 2008 Jan; 1189():236-46. PubMed ID: 18062938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic vesicle protein 2A mitigates parthanatos via apoptosis-inducing factor in a rat model of pharmacoresistant epilepsy.
    Li C; Wang Z; Ren M; Ren S; Wu G; Wang L
    CNS Neurosci Ther; 2024 May; 30(5):e14778. PubMed ID: 38801174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission.
    Tokudome K; Okumura T; Shimizu S; Mashimo T; Takizawa A; Serikawa T; Terada R; Ishihara S; Kunisawa N; Sasa M; Ohno Y
    Sci Rep; 2016 Jun; 6():27420. PubMed ID: 27265781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam.
    Kaminski RM; Gillard M; Leclercq K; Hanon E; Lorent G; Dassesse D; Matagne A; Klitgaard H
    Epilepsia; 2009 Jul; 50(7):1729-40. PubMed ID: 19486357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance-associated protein 1 decreases the concentrations of antiepileptic drugs in cortical extracellular fluid in amygdale kindling rats.
    Chen YH; Wang CC; Xiao X; Wei L; Xu G
    Acta Pharmacol Sin; 2013 Apr; 34(4):473-9. PubMed ID: 23474709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.
    van Vliet EA; Aronica E; Redeker S; Boer K; Gorter JA
    Epilepsia; 2009 Mar; 50(3):422-33. PubMed ID: 18717715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential increase in the hippocampal synaptic vesicle protein 2A (SV2A) by pentylenetetrazole kindling.
    Ohno Y; Ishihara S; Terada R; Kikuta M; Sofue N; Kawai Y; Serikawa T; Sasa M
    Biochem Biophys Res Commun; 2009 Dec; 390(3):415-20. PubMed ID: 19751703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced synaptic vesicle traffic in hippocampus of phenytoin-resistant kindled rats.
    Zeng K; Wang X; Wang Y; Yan Y
    Neurochem Res; 2009 May; 34(5):899-904. PubMed ID: 18841467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Differential Expression of Synaptic Vesicle Protein 2A in the Adult Rat Brain.
    Mendoza-Torreblanca JG; García-Cruz ME; Sánchez-Cruz I; Gomez-Gonzalez B; Juárez-Méndez S; Gómez-Lira G
    Neuroscience; 2019 Nov; 419():108-120. PubMed ID: 31520710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Function of synaptic vesicle protein 2A (SV2A) as a novel therapeutic target for epilepsy].
    Tokudome K; Shimizu S; Serikawa T; Ohno Y
    Nihon Yakurigaku Zasshi; 2018; 152(6):275-280. PubMed ID: 30531097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of drug-resistant epilepsy.
    Löscher W
    Novartis Found Symp; 2002; 243():149-59; discussion 159-66, 180-5. PubMed ID: 11990774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis.
    Ohno Y; Tokudome K
    CNS Neurol Disord Drug Targets; 2017; 16(4):463-471. PubMed ID: 28393712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal low-frequency stimulation inhibits afterdischarge and increases GABA (A) receptor expression in amygdala-kindled pharmacoresistant epileptic rats.
    Wu G; Wang L; Hong Z; Ren S; Zhou F
    Neurol Res; 2017 Aug; 39(8):733-743. PubMed ID: 28502217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kindling model of pharmacoresistant temporal lobe epilepsy in Sprague-Dawley rats induced by Coriaria lactone and its possible mechanism.
    Wang Y; Zhou D; Wang B; Li H; Chai H; Zhou Q; Zhang S; Stefan H
    Epilepsia; 2003 Apr; 44(4):475-88. PubMed ID: 12680996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME
    Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of multidrug resistance-associated protein 2 in the brain of pentylenetetrazole-kindled rats.
    Yao D; Liu L; Jin S; Li J; Liu XD
    Neuroscience; 2012 Dec; 227():283-92. PubMed ID: 23059797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.